MTM(SH:688029) Sou Hu Cai Jing·2025-08-20 11:16Group 1 - The core viewpoint of the articles highlights the performance and valuation of Nanwei Medical, which closed at 94.97 yuan with a PE ratio of 29.43 times, significantly lower than the industry average of 59.32 times [1][2] - As of June 30, 2025, the number of shareholders in Nanwei Medical decreased to 12,345, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including endoscopic diagnostic instruments and microwave/radiofrequency ablation equipment [1] Group 2 - In the latest financial report for the first half of 2025, Nanwei Medical achieved a revenue of 1.565 billion yuan, representing a year-on-year increase of 17.36%, and a net profit of 363 million yuan, also up by 17.04%, with a gross profit margin of 64.89% [1] - The industry average PE ratio stands at 59.32, while the median is 39.97, indicating that Nanwei Medical is undervalued compared to its peers [2] - The total market capitalization of Nanwei Medical is 17.84 billion yuan, placing it at the 58th position in the industry ranking [1][2]